CORC  > 四川大学
RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival
Fang, Aiping; Zhou, Shijie; Su, Xiaolan; Liu, Chuang; Chen, Xiaoxin; Wan, Yang; Lei, Xiaohong; Xie, Linshen; Jia, Yiping; Wang, Wenzhi
刊名FUTURE ONCOLOGY
2018
卷号Vol.14 No.25页码:2615-2625
关键词hepatocellular carcinoma overall survival RAMP3 recurrence-free survival
ISSN号1479-6694
URL标识查看原文
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/1837187
专题四川大学
作者单位1.Guangdong Zhongsheng Pharmaceut Co Ltd, Dongguan, Guangdong, Peoples R China
2.Sichuan Univ, Res Ctr Publ Hlth & Prevent Med, West China Sch Publ Hlth, Chengdu 610041, Sichuan, Peoples R China
3.Sichuan Univ, West China Hosp, Ctr Canc, Chengdu 610041, Sichuan, Peoples R China
4.Sichuan Univ, Hlth Food Evaluat Res Ctr, West China Teaching Hosp 4, Chengdu 610041, Sichuan, Peoples R China
推荐引用方式
GB/T 7714
Fang, Aiping,Zhou, Shijie,Su, Xiaolan,et al. RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival[J]. FUTURE ONCOLOGY,2018,Vol.14 No.25:2615-2625.
APA Fang, Aiping.,Zhou, Shijie.,Su, Xiaolan.,Liu, Chuang.,Chen, Xiaoxin.,...&Wang, Wenzhi.(2018).RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival.FUTURE ONCOLOGY,Vol.14 No.25,2615-2625.
MLA Fang, Aiping,et al."RAMP3 is a prognostic indicator of liver cancer and might reduce the adverse effect of TP53 mutation on survival".FUTURE ONCOLOGY Vol.14 No.25(2018):2615-2625.
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace